Alpha Omega Wealth Management LLC Biogen Inc. Transaction History

Alpha Omega Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $93,499 - $104,868	-430 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$216.71 - $338.96 $4,334 - $6,779	20 Added 4.88%	430 $102,000
Q4 2018 Jan 18, 2019	SELL	$278.5 - $352.75 $4,177 - $5,291	-15 Reduced 3.53%	410 $123,000
Q3 2017 Nov 03, 2017	BUY	$281.15 - $329.69 $28,114 - $32,969	100 Added 30.77%	425 $133,000
Q2 2017 Aug 07, 2017	BUY	N/A	325	325 $88,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Alpha Omega Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Omega Wealth Management LLC with notifications on news.